Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064229297> ?p ?o ?g. }
- W2064229297 endingPage "37334" @default.
- W2064229297 startingPage "37329" @default.
- W2064229297 abstract "Neutrophils are short-lived leukocytes that die by apoptosis. Whereas stress-induced apoptosis is mediated by the p38 mitogen-activated protein (MAP) kinase pathway (Frasch, S. C., Nick, J. A., Fadok, V. A., Bratton, D. L., Worthen, G. S., and Henson, P. M. (1998) J. Biol. Chem. 273, 8389–8397), signals regulating spontaneous neutrophil apoptosis have not been fully determined. In this study we found increased activation of protein kinase C (PKC)-β and -δ in neutrophils undergoing spontaneous apoptosis, but we show that only activation of PKC-δ was directly involved in the induction of apoptosis. PKC-δ can be proteolytically activated by caspase 3. We detected the 40-kDa caspase-generated fragment of PKC-δ in apoptotic neutrophils and showed that the caspase 3 inhibitor Asp-Glu-Val-Asp-fluoromethylketone prevented generation of the 40-kDa PKC-δ fragment and delayed neutrophil apoptosis. In a cell-free system, removal of PKC-δ by immunoprecipitation reduced DNA fragmentation, whereas loss of PKC-α, -β, or -ζ had no significant effect. Rottlerin and LY379196 inhibit PKC-δ and PKC-β, respectively. Only Rottlerin was able to delay neutrophil apoptosis. Inhibitors of MAP-ERK kinase 1 (PD98059) or p38 MAP kinase (SB202190) had no effect on neutrophil apoptosis, and activation of p42/44 and p38 MAP kinase did not increase in apoptotic neutrophils. We conclude that spontaneous neutrophil apoptosis involves activation of PKC-δ but is MAP kinase-independent. Neutrophils are short-lived leukocytes that die by apoptosis. Whereas stress-induced apoptosis is mediated by the p38 mitogen-activated protein (MAP) kinase pathway (Frasch, S. C., Nick, J. A., Fadok, V. A., Bratton, D. L., Worthen, G. S., and Henson, P. M. (1998) J. Biol. Chem. 273, 8389–8397), signals regulating spontaneous neutrophil apoptosis have not been fully determined. In this study we found increased activation of protein kinase C (PKC)-β and -δ in neutrophils undergoing spontaneous apoptosis, but we show that only activation of PKC-δ was directly involved in the induction of apoptosis. PKC-δ can be proteolytically activated by caspase 3. We detected the 40-kDa caspase-generated fragment of PKC-δ in apoptotic neutrophils and showed that the caspase 3 inhibitor Asp-Glu-Val-Asp-fluoromethylketone prevented generation of the 40-kDa PKC-δ fragment and delayed neutrophil apoptosis. In a cell-free system, removal of PKC-δ by immunoprecipitation reduced DNA fragmentation, whereas loss of PKC-α, -β, or -ζ had no significant effect. Rottlerin and LY379196 inhibit PKC-δ and PKC-β, respectively. Only Rottlerin was able to delay neutrophil apoptosis. Inhibitors of MAP-ERK kinase 1 (PD98059) or p38 MAP kinase (SB202190) had no effect on neutrophil apoptosis, and activation of p42/44 and p38 MAP kinase did not increase in apoptotic neutrophils. We conclude that spontaneous neutrophil apoptosis involves activation of PKC-δ but is MAP kinase-independent. mitogen-activated protein Asp-Glu-Val-Asp-fluoromethylketone protein kinase C extracellular signal-regulated kinase Neutrophils are short-lived terminally differentiated blood cells that play a vital role in inflammatory responses. Chemotactic factors generated at sites of infection induce the movement of neutrophils from the blood into the affected tissues. A variety of molecules, including cytokines and bacterial products, then activate the defense systems of the neutrophil, which include phagocytosis, degranulation, and activation of NADPH oxidase. Although neutrophils are crucial in the defense against infection, they have also been implicated in the pathogenesis of tissue injury seen in inflammatory diseases of the lung, kidney, joints, and other organs (1Edwards S.E. Biochemistry and Physiology of the Neutrophil. 1st Ed. Cambridge University Press, Cambridge and New York1994Crossref Google Scholar, 2Hogg J.C. Physiol. Rev. 1987; 67: 1249-1295Crossref PubMed Scopus (244) Google Scholar, 3Weiss S.J. N. Engl. J. Med. 1989; 320: 365-376Crossref PubMed Scopus (3855) Google Scholar). During the resolution of inflammation, effete neutrophils are removed from inflammatory sites by apoptosis, leading to their recognition and phagocytosis by macrophages (4Savill J.S. Wyllie A.H. Henson J.E. Walport M.J. Henson P.M. Haslett C. J. Clin. Invest. 1989; 83: 865-875Crossref PubMed Scopus (1351) Google Scholar). Any significant delay to neutrophil apoptosis can lead to excessive neutrophil accumulation and damage to healthy tissue (5Hallett M.B. Lloyds D. Immunol. Today. 1995; 16: 264-268Abstract Full Text PDF PubMed Scopus (229) Google Scholar). Although apoptosis is an intrinsic cell process, a variety of cytokines, primarily those that prime neutrophils (6Stringer R.E. Hart C.A. Edwards S.W. Br. J. Hematol. 1996; 92: 169-175Crossref PubMed Scopus (64) Google Scholar), are able to delay apoptosis. How these effects are achieved is not known, although the modulation of signaling pathways regulating apoptosis is an obvious target in such a short-lived cell. Members of the MAP1 kinase family of signaling enzymes, specifically, p38 MAP kinase, have been shown to be involved in accelerating neutrophil apoptosis in response to stress but do not appear to be involved in spontaneous neutrophil apoptosis (7Frasch S.C. Nick J.A. Fadok V.A. Bratton D.L. Worthen G.S. Henson P.M. J. Biol. Chem. 1998; 273: 8389-8397Abstract Full Text Full Text PDF PubMed Scopus (272) Google Scholar). An alternative signaling pathway that has been implicated in the regulation of apoptosis in a wide variety of cells (8Deacon E.M. Pongracz J. Griffiths G. Lord J.M. J. Clin. Pathol. Mol. Pathol. 1997; 50: 124-131Crossref Scopus (107) Google Scholar) is protein kinase C (PKC). PKC is a family of 11 isoenzymes that are well conserved across species, suggesting they have specific functions within cells (9Nishizuka Y. Science. 1992; 258: 607-614Crossref PubMed Scopus (4230) Google Scholar). Neutrophils have been shown to express several PKC isoenzymes including PKC-α, -β, -δ (10Majumdar S. Rossi M.W. Fujiki T. Phillips W.A. Disa S. Queen C.F. Johnston Jr., R.B. Rosen O.M. Corkey B.E. Korchak H.M. J. Biol. Chem. 1991; 266: 9285-9293Abstract Full Text PDF PubMed Google Scholar, 11Smallwood J.I. Malawista S.E. J. Leukocyte Biol. 1992; 51: 84-92Crossref PubMed Scopus (44) Google Scholar), and -ζ (12Dang P.M.C. Hakim J. Perianin A. FEBS Lett. 1995; 349: 338-342Crossref Scopus (67) Google Scholar). Selective involvement of PKC isoenzymes in the regulation of apoptosis has been indicated in recent studies in a variety of cells, including those of myeloid (13MacFarlane D.E. Manzel L. J. Biol. Chem. 1994; 269: 4327-4331Abstract Full Text PDF PubMed Google Scholar, 14Pongracz J. Deacon E.M. Johnson G.D. Burnett D. Lord J.M. Leuk. Res. 1996; 20: 319-326Crossref PubMed Scopus (21) Google Scholar, 15Evans C.A. Lord J.M. Owen-Lynch P.J. Johnson G. Dive C. Whetton A.D. J. Cell Sci. 1995; 108: 2591-2598Crossref PubMed Google Scholar) and lymphoid (16Knox K.A. Johnson G.D. Gordon J. Exp. Cell Res. 1993; 207: 68-73Crossref PubMed Scopus (46) Google Scholar, 17Lee J.Y. Hannun Y.A. Obeid L.M. J. Biol. Chem. 1996; 271: 13169-13174Abstract Full Text Full Text PDF PubMed Scopus (245) Google Scholar) origin. In Molt 4 cells, Lee et al. (17Lee J.Y. Hannun Y.A. Obeid L.M. J. Biol. Chem. 1996; 271: 13169-13174Abstract Full Text Full Text PDF PubMed Scopus (245) Google Scholar) have shown that ceramide induced apoptosis via the inhibition of PKC-α, and Whelan and Parker (18Whelan R.D.H. Parker P.J. Oncogene. 1998; 16: 1939-1944Crossref PubMed Scopus (137) Google Scholar) have shown that down-regulation of PKC-α induces apoptosis in COS cells, suggesting an anti-apoptotic role for this isoenzyme. In contrast, MacFarlane et al. (13MacFarlane D.E. Manzel L. J. Biol. Chem. 1994; 269: 4327-4331Abstract Full Text PDF PubMed Google Scholar) showed that PKC-β expression was required for promyeloid HL60 cells to undergo differentiation and apoptosis in response to phorbol ester treatment, and the expression of PKC-β was differentially regulated during apoptosis in myelomonocytic U937 cells (14Pongracz J. Deacon E.M. Johnson G.D. Burnett D. Lord J.M. Leuk. Res. 1996; 20: 319-326Crossref PubMed Scopus (21) Google Scholar). Also in U937 cells, PKC-δ has been shown to be activated by caspase 3, leading to the generation of a 40-kDa catalytic fragment after the induction of apoptosis by a variety of agents, including Fas ligation (19Ghayur T. Hugunin M. Talanian R.V. Ratnofsky S. Quinlan C. Emoto Y. Pandey P. Datta R. Huang Y. Kharbanda S. Allen H. Kamen R. Wong W. Kufe D. J. Exp. Med. 1996; 184: 2399-2404Crossref PubMed Scopus (447) Google Scholar). Thus, PKC isoenzymes appear to be differentially involved in the regulation of the apoptotic program. Although PKC has been implicated in signaling pathways regulating spontaneous apoptosis in promyeloid cells (20Pongracz J. Tuffley W. Johnson G.D. Deacon E.M. Burnett D. Stockley R.A. Lord J.M. Exp. Cell Res. 1995; 218: 430-438Crossref PubMed Scopus (52) Google Scholar), the involvement of PKC isoenzymes in neutrophil apoptosis has not been established. However, the Fas/Fas ligand system has been reported to be involved in mediating spontaneous neutrophil apoptosis (21Iwai K. Miyawaki T. Takizawa T. Konno A. Ohta K. Yachie A. Seki H. Taniguchi N. Blood. 1994; 84: 1201-1208Crossref PubMed Google Scholar), although the signaling pathways downstream of Fas ligation in the neutrophil have not been established. Because PKC-δ has been shown to be activated after Fas ligation in promyeloid cells (19Ghayur T. Hugunin M. Talanian R.V. Ratnofsky S. Quinlan C. Emoto Y. Pandey P. Datta R. Huang Y. Kharbanda S. Allen H. Kamen R. Wong W. Kufe D. J. Exp. Med. 1996; 184: 2399-2404Crossref PubMed Scopus (447) Google Scholar), a role for the activation of specific PKC isoenzymes in spontaneous neutrophil apoptosis was investigated. In this report, we show that both PKC-β and -δ were activated during apoptosis, although only the inhibition of PKC-δ delayed spontaneous neutrophil apoptosis. We also confirm that p42/44 and p38 MAP kinases are involved in stress-induced apoptosis but are not involved in the regulation of spontaneous neutrophil apoptosis. Venous blood (20–100 ml) was taken from healthy volunteers, and neutrophils were isolated on Percoll gradients as described previously (22Afford S.C. Pongracz J. Stockley R.A. Crocker J. Burnett D. J. Biol. Chem. 1992; 267: 21612-21616Abstract Full Text PDF PubMed Google Scholar). Neutrophil preparations contained >95% neutrophils. Neutrophils were resuspended in RPMI 1640 medium (Life Technologies, Inc.) supplemented with 10% heat-inactivated fetal calf serum (Life Technologies, Inc.) and 100 units/ml penicillin and 100 μg/ml streptomycin (Sigma) and used immediately as healthy control cells, or they were cultured in a humidified 5% CO2atmosphere to provide apoptotic cells. Cytospin preparations (3 min, 10 × g; Cytospin 2, Shandon) were made after 6 and 24 h of incubation, differentially stained using a commercial May-Grunwald Giemsa stain (Diff-Quick, Baxter Healthcare Products), and assessed for apoptotic morphology (22Afford S.C. Pongracz J. Stockley R.A. Crocker J. Burnett D. J. Biol. Chem. 1992; 267: 21612-21616Abstract Full Text PDF PubMed Google Scholar). PKC inhibitors, Go6976 and Rottlerin were purchased from Calbiochem and used at the concentrations shown. LY379196 is a novel PKC-β inhibitor (23Jirousek M.R. Gillig J.R. Heath W.F. Gonzalez C.M. McDonald III, J.H. Neel D.A. Rito C.J. Stramm L.E. Singh U. Melikian-Badalian A. Baevsky M. Ballas L.M. Hall S.E. Winneroski L.L. Faul M.M. J. Med. Chem. 1996; 39: 2664-2671Crossref PubMed Scopus (325) Google Scholar) and was kindly provided by Eli Lilly and used at 10 nm. The caspase 3 inhibitor DEVD-fmk (Calbiochem) was used at 20 μm. Inhibition of caspase 3 was confirmed by assaying caspase 3 activity in 100 μl of neutrophil cell lysates, using a commercial kit and according to manufacturer's instructions (CaspAce; Promega). The MAP-ERK kinase and p38 MAP kinase inhibitors, PD98059 and SB202190 (Calbiochem), were used at 30 and 10 μm,respectively. All inhibitors were included in the incubation medium, and apoptosis was assessed by morphology after 6 h or overnight treatment. PKC activation was assessed by determining the translocation of PKC from the cytosol to the particulate fraction of neutrophils (24Griffiths G. Garrone B. Deacon E. Owen P. Pongracz J. Mead G. Bradwell A.R. Watters D. Lord J. Biochem. Biophys. Res. Commun. 1996; 222: 802-808Crossref PubMed Scopus (78) Google Scholar). Briefly, neutrophils were resuspended in Buffer A (20 mm Tris/HCl buffer, pH 7.5, and 1.5 mm EGTA supplemented with 1.5 mmphenylmethylsulfonyl fluoride, 50 μg/ml leupeptin, 10 μg/ml aprotinin, and 10 μg/ml pepstatin) and lysed by freezing and thawing in liquid nitrogen. The cell lysate was spun (100,000 ×g, 4 °C, 30 min), and the supernatant was removed and treated as the cytosol extract. Particulate proteins were then extracted from the resulting pellet by incubation for 10 min on ice in Buffer A containing 0.5% (v/v) Triton X-100. Degradation of PKC during the fractionation of neutrophils was monitored by Western blotting and was not greater than 5% for any of the isoenzymes tested. Protein concentrations were determined in cytosol and particulate preparations, and the samples were boiled in SDS sample buffer. Equivalent amounts of protein were separated on 12% SDS-polyacrylamide gels and transferred to polyvinylidene difluoride membrane (Immobilon-P; Millipore UK, Ltd). PKC isoenzyme immunoreactivity was detected with rabbit polyclonal antibodies to PKC-α, -β, and -δ (Santa Cruz Biotechnology). The anti-PKC-ζ antibody (25Tsutsumi A. Kubo M. Fujii H. Freire-Moar J. Turck C.W. Ransom J.T. J. Immunol. 1993; 150: 1746-1754PubMed Google Scholar) was an anti-peptide antibody raised in rabbits and was a kind gift from Dr. J. Ransom (Syntex Research Ltd., Palo Alto, CA). Horseradish peroxidase-conjugated sheep anti-rabbit IgG antibody (Amersham International) was used as a secondary antibody. Enhanced chemiluminescence (ECL; Amersham International) was used to reveal immunoreactive bands. 10 ng of human recombinant PKC for each isoenzyme (Calbiochem) was applied to the outer lane in each gel to confirm antibody specificity. The subcellular distribution of PKC isoenzymes was assessed using indirect immunofluorescence staining and confocal microscopy. Cytospin preparations were made of apoptotic and non-apoptotic neutrophils and air dried for at least 1 h before fixing in 4% paraformaldehyde for 10 min. Cells were incubated with antibody to PKC-δ (Santa Cruz Biotechnology) for 30 min at room temperature in a humidified atmosphere and incubated with fluorescein isothiocyanate-conjugated secondary antibody for an additional 30 min. Nuclei were counterstained with propidium iodide. Fading of fluorescence was retarded by treatment of stained cells with 2.5% (w/v) 1,4-diazobicyclo(2,2,2)-octane (DABCO; BDH Ltd.) in 80% glycerol. Immunofluorescence was analyzed by laser scanning confocal microscopy using a MRC 500 confocal microscope (Bio-Rad). Protein extracts from freshly isolated neutrophils and neutrophils cultured overnight were separated on 10% SDS-polyacrylamide gel electrophoresis gels and analyzed by Western blotting using antibodies specific for the phosphorylated, active forms of p42/44 and p38 MAP kinase (Promega). Immunoreactive bands were revealed by enhanced chemiluminescence. Nuclei were isolated from neutrophils using a rapid procedure developed for hemopoietic cells (26Bunce C.M. Thick J.A. Lord J.M. Mills D. Brown G. Anal. Biochem. 1988; 175: 67-73Crossref PubMed Scopus (37) Google Scholar). Cytosol was prepared from neutrophils incubated for 24 h to give >75% apoptotic cells. Neutrophils were lysed in Buffer A and spun at 100,000 × g to recover the cytosol (supernatant) fraction. Healthy nuclei were combined with apoptotic cytosol, and DNA fragmentation was measured after 30 min using an enzyme-linked immunosorbent assay-based commercial kit (Roche Molecular Biochemicals). To deplete PKC isoenzymes, the apoptotic cytosol was incubated with PKC isoenzyme antibodies (Santa Cruz Biotechnology) at 10 μg/ml extract for 30 min at 4 °C, followed by a mouse anti-rabbit IgG antibody and protein A coupled to agarose beads (Upstate Biotechnology). Immunocomplexes were removed by centrifugation, and the remaining cytosol was combined with the healthy nuclei. Depletion of PKC was confirmed by Western blotting. Mouse immunoglobulin G was used as control. Data presented here represent a minimum of three experiments, and, where appropriate, data are expressed as mean ± SD. Statistical significance was assessed by Student's ttest, and p < 0.05 was taken as a significantly different value. The level of apoptosis in freshly isolated neutrophils (Fig. 1) was low (2.2 ± 0.7%;n = 5) and increased significantly as cells were aged in culture to 11.6 ± 5.1% after 6 h (p < 0.05; n = 5) and 68.0 ± 15% after 24 h (p < 0.001; n = 5). PKC resides in the cytosol in the inactive state and is translocated to the membrane fraction upon activation. Assessment of particulate (membrane) and cytosolic PKC can thus give an indication of enzyme activation. Immunoblotting of neutrophil particulate and cytosolic protein extracts revealed an increase in PKC-β and -δ isoenzymes associated with the particulate fraction during apoptosis (Fig. 2 A). Translocation of PKC-α was not detected, and the majority of PKC-α was located in the cytosol. PKC-ζ was also detected only in the cytosol fraction of neutrophils, but its subcellular localization did not alter as neutrophils were aged in culture (Fig. 2 A). PKC-δ can also be activated by caspase 3. A 40-kDa fragment of PKC-δ was not detected in freshly isolated neutrophils, and only the full-length 78-kDa form was seen. However, as cells were aged overnight in culture and entered apoptosis, a 40-kDa fragment was detected, and the level of the 78-kDa PKC-δ was reduced concomitantly (Fig. 2 B). The appearance of the 40-kDa PKC-δ fragment was reduced when DEVD-fmk was included in the medium (Fig. 2 B), confirming that generation of the active fragment of PKC-δ was mediated by caspase 3. Inhibition of caspase 3 activity by DEVD-fmk was confirmed in the same extracts (Fig. 2 C). Although PKC-ζ can also be cleaved by caspase 3, we did not detect the cleaved form of this isoenzyme in neutrophils (data not shown). To determine whether the activation of PKC-β and -δ seen in apoptotic cells was involved in the apoptotic process, three PKC isoenzyme-selective inhibitors were used. Go6976 inhibits the classical PKC isoenzymes (PKC-α, -β, and -γ), LY379196 is a PKC-β-specific inhibitor (23Jirousek M.R. Gillig J.R. Heath W.F. Gonzalez C.M. McDonald III, J.H. Neel D.A. Rito C.J. Stramm L.E. Singh U. Melikian-Badalian A. Baevsky M. Ballas L.M. Hall S.E. Winneroski L.L. Faul M.M. J. Med. Chem. 1996; 39: 2664-2671Crossref PubMed Scopus (325) Google Scholar), and Rottlerin inhibits PKC-δ (27Gscwendt M. Muller H.J. Kielbassa K. Zang R. Kittstein W. Rincke G. Marks F. Biochem. Biophys. Res. Commun. 1994; 199: 93-97Crossref PubMed Scopus (760) Google Scholar). Because PKC-δ can be activated by caspase 3, the effect of the caspase 3 inhibitor (DEVD-fmk) on neutrophil apoptosis was also determined. Go6976 and LY379196 did not decrease apoptosis in neutrophil cultures after an overnight incubation (Fig. 3 A). However, Rottlerin and DEVD-fmk inhibited neutrophil apoptosis significantly (Fig. 3 A). The inhibition of PKC isoenzymes by the inhibitors used was confirmed by Western blotting of neutrophil cytosol and particulate extracts (Fig. 3 B). To attempt to confirm the data gained with pharmacological inhibitors of PKC isoenzymes, a cell-free system was used. Nuclei were isolated from non-apoptotic neutrophils and combined with cytosol from apoptotic neutrophils after the removal of individual PKC isoenzymes by immunoprecipitation (Fig. 4 A). Apoptosis was then assessed using an enzyme-linked immunosorbent assay method to detect DNA fragmentation. Cytosol from apoptotic neutrophils (A+) induced a significant increase in DNA fragmentation in non-apoptotic nuclei, compared with the addition of cytosol from healthy neutrophils (A0, Fig. 4 B). The removal of PKC-δ by immunoprecipitation significantly decreased DNA fragmentation induced by the apoptotic cytosol. Loss of PKC-β gave a slight but not significant reduction in DNA fragmentation, and removal of PKC-α or -ζ or the addition of a mouse IgG had no effect (Fig. 4 B). Inhibitors of MAP-ERK kinase 1 (PD98059), which lies upstream of p42/44 MAP kinase, and p38 MAP kinase (SB202190) were used to determine whether members of the MAP kinase family were involved in the regulation of spontaneous neutrophil apoptosis. Neither of these agents affected the level of neutrophil apoptosis when they were included in the culture medium for 6 h (data not shown) or overnight (Fig. 5 A). In addition, activated p42/44 MAP kinase and p38 MAP kinase detected by antibodies specific for the active forms of these kinases were barely detectable in freshly isolated or spontaneously apoptotic neutrophils (Fig. 5 B). In contrast, activated p38 MAP kinase was present at a high level in neutrophils induced to die by UV irradiation (Fig. 5 B), and p42/44 MAP kinase was activated by treatment of neutrophils with phorbol myristic acid (Fig. 5 B). The Western blotting data indicating PKC-δ translocation to the particulate fraction were investigated further by immunohistochemistry. Comparison of PKC-δ immunostaining in freshly isolated neutrophils (Fig. 6 A) and neutrophils cultured for 8 h (Fig. 6 B) revealed an increase in PKC-δ associated with the nucleus in many cells. The increase in nuclear PKC-δ was quantitated by determining the percentage of total PKC-δ fluorescence that was coincident with the red fluorescence of the propidium iodide nuclear counterstain. In each study, 100 cells were examined, and the mean value for nuclear PKC-δ increased from 7.7 ± 0.4% in healthy neutrophils to 21.4 ± 1.5% in neutrophils cultured for 8 h. Staining of neutrophils aged for a longer time period in culture was not possible because these cells were more fragile and were not suitable for immunostaining. Much research has focused on the apoptotic program in proliferating cells, but little is known about the regulation of apoptosis in fully differentiated cells, such as neutrophils. However, the pathological consequences of an altered neutrophil life span are considerable (1Edwards S.E. Biochemistry and Physiology of the Neutrophil. 1st Ed. Cambridge University Press, Cambridge and New York1994Crossref Google Scholar, 2Hogg J.C. Physiol. Rev. 1987; 67: 1249-1295Crossref PubMed Scopus (244) Google Scholar, 3Weiss S.J. N. Engl. J. Med. 1989; 320: 365-376Crossref PubMed Scopus (3855) Google Scholar). In this study, the involvement of PKC isoenzymes and MAP kinases in spontaneous neutrophil apoptosis has been investigated. We confirmed previous reports that p38 MAP kinase is involved in inducing signals for neutrophil death in response to stress (7Frasch S.C. Nick J.A. Fadok V.A. Bratton D.L. Worthen G.S. Henson P.M. J. Biol. Chem. 1998; 273: 8389-8397Abstract Full Text Full Text PDF PubMed Scopus (272) Google Scholar). However, the p38 MAP kinase pathway is not involved in spontaneous apoptosis, suggesting that this pathway in the neutrophil may be activated solely in response to stress-induced apoptosis. PKC is known to be involved in neutrophil activation and in the regulation of apoptosis in a variety of cells. The 11 PKC isoenzymes appear to play various roles in the regulation of apoptosis (8Deacon E.M. Pongracz J. Griffiths G. Lord J.M. J. Clin. Pathol. Mol. Pathol. 1997; 50: 124-131Crossref Scopus (107) Google Scholar), but PKC-δ is consistently a pro-apoptotic PKC isoenzyme. PKC-δ can be cleaved by caspase 3, and transfection of cells with the caspase-generated catalytic fragment of PKC-δ is sufficient to induce apoptosis (28Emoto Y. Manome Y. Meinhardt G. Kisaki H. Kharbanda S. Robertson M. Ghayur T. Wong W.W. Kamen R. Weichselbaum R. Kufe D. EMBO J. 1995; 14: 6148-6156Crossref PubMed Scopus (652) Google Scholar). The data reported here show that PKC-δ is activated during spontaneous neutrophil apoptosis. Furthermore, inhibition of PKC-δ activation by either use of a selective inhibitor or inhibition of caspase 3 delayed neutrophil apoptosis significantly. The caspase 3 inhibitor produced a greater delay in apoptosis than the PKC-δ inhibitor. This is not surprising, because PKC-δ is one of the many targets of this protease. Other substrates of caspase 3 include ICAD, the inhibitor of the apoptosis-specific endonuclease caspase-activated DNase (29Enari M. Sakahira H. Yokoyama H. Okawa K. Iwamatsu A. Nagata S. Nature. 1998; 393: 396-400Crossref Scopus (17) Google Scholar), and cytoskeletal proteins such as actin (30Mashima T. Naito M. Tsuruo T. Oncogene. 1999; 18: 2423-2430Crossref PubMed Scopus (168) Google Scholar) and fodrin (31Janicke R.U. Ng P. Sprengart M.L. Porter A.G. J. Biol. Chem. 1998; 273: 15540-15545Abstract Full Text Full Text PDF PubMed Scopus (444) Google Scholar). Thus, inhibition of PKC-δ may remove one of the elements of the apoptotic program but would not be able to prevent it altogether. Until recently, PKC-δ and the very closely related isoform PKC-θ were the only PKC isoenzymes reported to undergo proteolytic cleavage and activation by caspase 3. It has now been shown that PKC-ζ can also be cleaved by caspase 3, but in this case, apoptosis was associated with inhibition of PKC-ζ enzyme activity rather than activation (32Frutos S. Moscat J. Diaz-Meco M.T. J. Biol. Chem. 1999; 274: 10765-10770Abstract Full Text Full Text PDF PubMed Scopus (82) Google Scholar). Thus, activation of caspase 3 during apoptosis can result in the cleavage of both PKC-δ and -ζ, simultaneously effecting the activation of a pro-apoptotic PKC and the inhibition of an anti-apoptotic PKC isoenzyme. Although PKC-ζ was expressed in neutrophils, we did not detect proteolytic cleavage in spontaneously apoptotic neutrophils. Therefore, this pathway may either operate only in certain cells or be activated only during stress-induced apoptosis. We detected translocation of PKC-β in apoptotic neutrophils but did not detect proteolytic fragmentation of this isoenzyme. In a cell-free system, depletion of PKC-β from apoptotic cytosol did not significantly reduce DNA fragmentation in healthy nuclei, and the PKC-β inhibitor LY379196 did not delay neutrophil apoptosis. These data do not support a primary role for PKC-β in spontaneous apoptosis. Moreover, PKC-β has been proposed to play a role in neutrophil activation rather than apoptosis and may be involved in NADPH complex assembly and superoxide generation (33Parmer T.G. Ward M.D. Hait W.N. Cell Growth Differ. 1997; 8: 327-334PubMed Google Scholar, 34Nairn A.C. Picciolto M.R. Semin. Cancer Biol. 1994; 5: 295-303Crossref PubMed Scopus (21) Google Scholar). We excluded the possibility that PKC-β translocation was associated with activation of neutrophils in these studies by measuring superoxide generation. None was detected, suggesting that the translocation of PKC-β is an apoptosis-associated event. The data reported here suggest that PKC isoenzymes play several roles in the regulation of spontaneous neutrophil apoptosis, with PKC-δ playing a key role. Because p38 MAP kinase was not activated during spontaneous neutrophil apoptosis, we propose that PKC-δ represents a primary signaling pathway, maintaining a basal rate of spontaneous apoptosis. Additional pathways can be recruited to increase the rate of neutrophil death, including the MAP kinase pathway, in situations requiring accelerated apoptosis. The upstream mechanisms leading to activation of caspase 3 and PKC-δ in spontaneous neutrophil apoptosis are still unclear. Ligation of Fas has been suggested (21Iwai K. Miyawaki T. Takizawa T. Konno A. Ohta K. Yachie A. Seki H. Taniguchi N. Blood. 1994; 84: 1201-1208Crossref PubMed Google Scholar) because neutrophils express both Fas and its ligand. However, this is unlikely because Fas-blocking antibodies are ineffective (35Brown S.B. Savill J. J. Immunol. 1999; 162: 480-485PubMed Google Scholar). An alternative explanation is that spontaneous apoptosis is a result of cytokine deprivation; several pro-inflammatory cytokines are able to prevent neutrophil apoptosis (6Stringer R.E. Hart C.A. Edwards S.W. Br. J. Hematol. 1996; 92: 169-175Crossref PubMed Scopus (64) Google Scholar, 36Lee A. Whyte M.K.B. Haslett C. J. Leukocyte Biol. 1993; 54: 283-288Crossref PubMed Scopus (673) Google Scholar). Furthermore, we have shown recently that cytokine deprivation-induced apoptosis of T cells also involves activation of PKC-δ (37Scheel-Toellner D. Pilling D. Akbar A.N. Hardie D. Lombardi D. Salmon M. Lord J.M. Eur. J. Immunol. 1999; 29: 2603-2612Crossref PubMed Scopus (84) Google Scholar). The association of PKC-δ with the nucleus during apoptosis and its subsequent activation by caspase 3 have recently been reported in U937 cells after ionizing irradiation (38Bharti A. Kraeft S-K. Gounder M. Pandey P. Jin S. Yuan Z.-M. Lees-Miller S.P. Weichselbaum R. Weaver D. Chen L.B. Kufe D. Kharbanda S. Mol. Cell. Biol. 1998; 18: 6719-6728Crossref PubMed Scopus (201) Google Scholar) and during cytokine deprivation and Fas-induced apoptosis in T cells (37Scheel-Toellner D. Pilling D. Akbar A.N. Hardie D. Lombardi D. Salmon M. Lord J.M. Eur. J. Immunol. 1999; 29: 2603-2612Crossref PubMed Scopus (84) Google Scholar). Nuclear translocation of PKC-δ may therefore be an early event in the apoptotic program, preceding the common pathway that follows caspase 3 activation. The tyrosine kinase c-abl can be activated by ionizing irradiation, resulting in phosphorylation of PKC-δ and translocation to the nucleus. Tyrosine phosphorylation may be a general mechanism for nuclear translocation of PKC-δ. In summary, PKC isoenzymes play several distinct roles in the regulation of spontaneous neutrophil apoptosis. The translocation of PKC-δ to the nucleus and its activation by caspase 3 appear to be crucial events. PKC-δ may therefore represent a useful therapeutic target in conditions of disregulated neutrophil apoptosis. We are grateful to Mike Salmon for critical discussion of the manuscript." @default.
- W2064229297 created "2016-06-24" @default.
- W2064229297 creator A5002521571 @default.
- W2064229297 creator A5033276535 @default.
- W2064229297 creator A5043832238 @default.
- W2064229297 creator A5048287553 @default.
- W2064229297 creator A5048779996 @default.
- W2064229297 creator A5071970583 @default.
- W2064229297 date "1999-12-01" @default.
- W2064229297 modified "2023-10-02" @default.
- W2064229297 title "Spontaneous Neutrophil Apoptosis Involves Caspase 3-mediated Activation of Protein Kinase C-δ" @default.
- W2064229297 cites W1526569781 @default.
- W2064229297 cites W1568624108 @default.
- W2064229297 cites W1580727347 @default.
- W2064229297 cites W1630137952 @default.
- W2064229297 cites W1681184579 @default.
- W2064229297 cites W1750774965 @default.
- W2064229297 cites W1901058453 @default.
- W2064229297 cites W1943033915 @default.
- W2064229297 cites W1968442371 @default.
- W2064229297 cites W1969669060 @default.
- W2064229297 cites W1979847049 @default.
- W2064229297 cites W1982005911 @default.
- W2064229297 cites W1986956692 @default.
- W2064229297 cites W1993414868 @default.
- W2064229297 cites W1996121260 @default.
- W2064229297 cites W1997926000 @default.
- W2064229297 cites W2035008428 @default.
- W2064229297 cites W2043356386 @default.
- W2064229297 cites W2085192592 @default.
- W2064229297 cites W2086524338 @default.
- W2064229297 cites W2088189246 @default.
- W2064229297 cites W2088603375 @default.
- W2064229297 cites W2088826163 @default.
- W2064229297 cites W2093881154 @default.
- W2064229297 cites W2106065518 @default.
- W2064229297 cites W2112914682 @default.
- W2064229297 cites W2113990199 @default.
- W2064229297 cites W2133037422 @default.
- W2064229297 cites W2133991390 @default.
- W2064229297 cites W2142332666 @default.
- W2064229297 cites W2178558243 @default.
- W2064229297 cites W2319498663 @default.
- W2064229297 cites W2321438790 @default.
- W2064229297 cites W2398303517 @default.
- W2064229297 cites W4214589643 @default.
- W2064229297 cites W4379136709 @default.
- W2064229297 doi "https://doi.org/10.1074/jbc.274.52.37329" @default.
- W2064229297 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10601300" @default.
- W2064229297 hasPublicationYear "1999" @default.
- W2064229297 type Work @default.
- W2064229297 sameAs 2064229297 @default.
- W2064229297 citedByCount "185" @default.
- W2064229297 countsByYear W20642292972012 @default.
- W2064229297 countsByYear W20642292972013 @default.
- W2064229297 countsByYear W20642292972014 @default.
- W2064229297 countsByYear W20642292972015 @default.
- W2064229297 countsByYear W20642292972016 @default.
- W2064229297 countsByYear W20642292972018 @default.
- W2064229297 countsByYear W20642292972019 @default.
- W2064229297 countsByYear W20642292972020 @default.
- W2064229297 countsByYear W20642292972021 @default.
- W2064229297 countsByYear W20642292972022 @default.
- W2064229297 countsByYear W20642292972023 @default.
- W2064229297 crossrefType "journal-article" @default.
- W2064229297 hasAuthorship W2064229297A5002521571 @default.
- W2064229297 hasAuthorship W2064229297A5033276535 @default.
- W2064229297 hasAuthorship W2064229297A5043832238 @default.
- W2064229297 hasAuthorship W2064229297A5048287553 @default.
- W2064229297 hasAuthorship W2064229297A5048779996 @default.
- W2064229297 hasAuthorship W2064229297A5071970583 @default.
- W2064229297 hasBestOaLocation W20642292971 @default.
- W2064229297 hasConcept C124160383 @default.
- W2064229297 hasConcept C12519072 @default.
- W2064229297 hasConcept C184235292 @default.
- W2064229297 hasConcept C185592680 @default.
- W2064229297 hasConcept C190283241 @default.
- W2064229297 hasConcept C31573885 @default.
- W2064229297 hasConcept C55493867 @default.
- W2064229297 hasConcept C86803240 @default.
- W2064229297 hasConcept C90934575 @default.
- W2064229297 hasConcept C95444343 @default.
- W2064229297 hasConcept C97029542 @default.
- W2064229297 hasConcept C98424977 @default.
- W2064229297 hasConceptScore W2064229297C124160383 @default.
- W2064229297 hasConceptScore W2064229297C12519072 @default.
- W2064229297 hasConceptScore W2064229297C184235292 @default.
- W2064229297 hasConceptScore W2064229297C185592680 @default.
- W2064229297 hasConceptScore W2064229297C190283241 @default.
- W2064229297 hasConceptScore W2064229297C31573885 @default.
- W2064229297 hasConceptScore W2064229297C55493867 @default.
- W2064229297 hasConceptScore W2064229297C86803240 @default.
- W2064229297 hasConceptScore W2064229297C90934575 @default.
- W2064229297 hasConceptScore W2064229297C95444343 @default.
- W2064229297 hasConceptScore W2064229297C97029542 @default.
- W2064229297 hasConceptScore W2064229297C98424977 @default.
- W2064229297 hasIssue "52" @default.
- W2064229297 hasLocation W20642292971 @default.